Schedule 4 to the Principal Order is amended as follows:

(a) by omitting item 40471 and substituting the following:

40471.	Diclofenac except –
	(a) when included in Schedule 2 or 3 ; or
	(b) in preparations for dermal use unless –
	(i) for the treatment of solar keratosis; or
	(ii) containing more than 1% of diclofenac.

(b) by inserting after item 40934 the following:

40934M.

Mercurochrome except when included in Schedule 2 or 6 .

(c) by inserting after item 41106 the following:

41106M.

Ofatumumab.

(d) by inserting after item 41338K the following:

41338L.

Rilpivirine.

(e) by inserting after item 41546 the following:

41546M.

Tolvaptan.

(f) by inserting after item 41624 the following:

41624M.

Vinflunine.

Displayed and numbered in accordance with the Rules Publication Act 1953 .

Notified in the Gazette on 1 June 2011

This order is administered in the Department of Health and Human Services.

EXPLANATORY NOTE

(This note is not part of the order)

This order amends the Poisons List Order 2001 by incorporating changes recommended by the National Drugs and Poisons Schedule Committee in the Standard for the Uniform Scheduling of Medicines and Poisons No. 1, Amendment No. 2.